Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors (Q33793673)

29 July 2017

1 reference

title

Pharmacological modulation of nitric oxide synthesis by mechanism-based inactivators and related inhibitors (English)

1 reference

29 July 2017

Bryk R

1

1 reference

PubMed ID

10596904

29 July 2017

Wolff DJ

series ordinal

2

1 reference

29 July 2017

1 November 1999

1 reference

Pharmacology & Therapeutics

29 July 2017

1 reference

29 July 2017

84

1 reference

29 July 2017

2

1 reference

29 July 2017

157-178

1 reference

Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Analysis of neuronal NO synthase under single-turnover conditions: conversion of Nomega-hydroxyarginine to nitric oxide and citrulline

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide and airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. Evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

L-arginine transport is increased in macrophages generating nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Delineation of the arginine- and tetrahydrobiopterin-binding sites of neuronal nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inducible nitric oxide synthase: identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide in excitable tissues: physiological roles and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide: a novel mediator of inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

The structure of nitric oxide synthase oxygenase domain and inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Structure of nitric oxide synthase oxygenase dimer with pterin and substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Immunochemical identification of an irreversibly bound heme-derived adduct to cytochrome P-450 following CCl4 treatment of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inactivation of cytochrome P-450 and production of N-alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridines. Structural requirements for loss of haem and alkylation of the pyrrole nitrogen atom

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Endogenous nitric oxide in cardiovascular disease and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Interaction of dihydropyridine Ca2+ agonist Bay K 8644 with normal and transformed pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

NO synthase isozymes have distinct substrate binding sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

NG-amino-L-arginine: a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Active site topologies and cofactor-mediated conformational changes of nitric-oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Macrophage NO synthase: characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Tetrahydrobiopterin-Free Neuronal Nitric Oxide Synthase: Evidence for Two Identical Highly Anticooperative Pteridine Binding Sites†

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthases: properties and catalytic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Covalent modification of lysine during the suicide inactivation of rat liver cytochrome P-450 by chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Selective inhibitors of cytochromes P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Secobarbital-mediated inactivation of cytochrome P450 2B1 and its active site mutants. Partitioning between heme and protein alkylation and epoxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Targeted disruption of the neuronal nitric oxide synthase gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Bright and dark sides of nitric oxide in ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Roles of nitric oxide in surgical infection and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Brain nitric oxide synthase is a haemoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

An examination of the role of increased cytosolic free Ca2+ concentrations in the inhibition of mRNA translation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Calmodulin-dependent regulation of inducible and neuronal nitric-oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide and its role in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Identification of the domains of neuronal nitric oxide synthase by limited proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Identification of nitric oxide synthase as a protective locus against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

On the mechanism of nitric oxide formation upon oxidative cleavage of C = N(OH) bonds by NO-synthases and cytochromes P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthase: Aspects concerning structure and catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO. as a cellular signal.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Biosynthesis and action of nitric oxide in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Identification of N-iminoethyl-l-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Suppression of arthritis by an inhibitor of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthases: which, where, how, and why?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide in inflammation and immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Molecular mechanisms and therapeutic strategies related to nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inducible nitric oxide synthase: what difference does it make?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthases: Roles, tolls, and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

NG-allyl- and NG-cyclopropyl-L-arginine: two novel inhibitors of macrophage nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of the inactivation of nitric oxide synthase by NG-methyl-L-arginine: evidence for heme loss

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Free radical modification of prosthetic heme groups

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Mechanism-based inactivation of cytochrome P450: isolation and characterization of N-alkyl heme adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Suicidal destruction of cytochrome P-450 during oxidative drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Covalent bonding of the prosthetic heme to protein: a potential mechanism for the suicide inactivation or activation of hemoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of the L-arginine:nitric oxide pathway in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Endothelial nitric-oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca2+

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Characterization by electron paramagnetic resonance of the interactions of L-arginine and L-thiocitrulline with the heme cofactor region of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Role of NO in vascular smooth muscle and cardiac muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Heme iron reduction and catalysis by a nitric oxide synthase heterodimer containing one reductase and two oxygenase domains

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Selective pharmacological inhibition of distinct nitric oxide synthase isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Mechanism-based inactivation of bovine adrenal cytochromes P450 C-21 and P450 17 alpha by 17 beta-substituted steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Interaction of calmodulin with the inducible murine macrophage nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Structure-function aspects in the nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

The calmodulin-nitric oxide synthase interaction. Critical role of the calmodulin latch domain in enzyme activation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide in hypertension and renal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide and the surgical patient. Identifying therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Suicide substrates, mechanism-based enzyme inactivators: recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Tetrahydrobiopterin-deficient nitric oxide synthase has a modified heme environment and forms a cytochrome P-420 analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Identification of a specific amino acid cluster in the calmodulin-binding domain of the neuronal nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Induction of calcium-dependent nitric oxide synthases by sex hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthase is a cytochrome P-450 type hemoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Endothelial nitric oxide synthase and LTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Arginine metabolism: nitric oxide and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Complementation analysis of mutants of nitric oxide synthase reveals that the active site requires two hemes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900030-3

7 January 2021

10.1016/S0163-7258(99)00030-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10596904